Ledger.Open graph →
SEC Form D · filed October 10, 2013

GENOCEA BIOSCIENCES, INC

Offering
$400K
Sold
$400K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Shawn L. Katz · New York, NYDirectorSeth Hetherington · CAMBRIDGE, MAExecMelvin L. Kupperman · New York, NYDirectorRobert Paull · CAMBRIDGE, MADirectorRobert E. Farrell Jr · CAMBRIDGE, MAExecKevin Bitterman · CAMBRIDGE, MADirectorLisa L. Silverstein · New York, NYExecStephen Hoffman · CAMBRIDGE, MADirectorRavi Venkataramani · CAMBRIDGE, MAExecTal S. Kerret · New York, NYExec · DirectorSimeon George · CAMBRIDGE, MADirectorPaul Giannasca · CAMBRIDGE, MAExecTimothy N. Yuckman · Birmingham, ALExecSwaroop Kolluri · Cambridge, MADirectorTom Bacon · HOUSTON, TXDirectorJordan Jones · Birmingham, ALExec · DirectorRichard E. Kaufman · Menlo Park, CADirectorMonika A. De Martini · Menlo Park, CADirectorRick Anderson · Austin, TXDirectorFrederic H. Moll · Menlo Park, CAExecCasper De Clercq · Palo Alto, CAExecVictor Kats · St. Louis, MOExecRachel J. Cherney · Santa Ana, CAExecRobb Fujioka · El Segundo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗